Does GOLIMUMAB Cause Pustular psoriasis? 258 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 258 reports of Pustular psoriasis have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 0.4% of all adverse event reports for GOLIMUMAB.
258
Reports of Pustular psoriasis with GOLIMUMAB
0.4%
of all GOLIMUMAB reports
159
Deaths
180
Hospitalizations
How Dangerous Is Pustular psoriasis From GOLIMUMAB?
Of the 258 reports, 159 (61.6%) resulted in death, 180 (69.8%) required hospitalization, and 159 (61.6%) were considered life-threatening.
Is Pustular psoriasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 258 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Pustular psoriasis?
ADALIMUMAB (685)
SECUKINUMAB (417)
METHOTREXATE (389)
ETANERCEPT (345)
INFLIXIMAB (326)
CERTOLIZUMAB PEGOL (310)
HYDROXYCHLOROQUINE (276)
USTEKINUMAB (276)
LEFLUNOMIDE (245)
TOCILIZUMAB (233)
Which GOLIMUMAB Alternatives Have Lower Pustular psoriasis Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN